Valbiotis (XPAR:ALVAL) ROE % Adjusted to Book Value : -17.31% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Valbiotis ROE % Adjusted to Book Value?

Valbiotis's ROE % for the quarter that ended in Dec. 2023 was -69.58%. Valbiotis's PB Ratio for the quarter that ended in Dec. 2023 was 4.02. Valbiotis's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -17.31%.

Valbiotis ROE % Adjusted to Book Value Historical Data

The historical data trend for Valbiotis's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valbiotis ROE % Adjusted to Book Value Chart

Valbiotis Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-36.04

-7.62

-17.37

-26.66

-11.12

Valbiotis Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial											-13.62	-13.94	-37.13	-6.72	-17.31

Competitive Comparison of Valbiotis's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Valbiotis's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valbiotis's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valbiotis's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Valbiotis's ROE % Adjusted to Book Value falls into.

Valbiotis ROE % Adjusted to Book Value Calculation

Valbiotis's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-44.71%	/	4.02
	=	-11.12%

Valbiotis's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-69.58%	/	4.02
	=	-17.31%

Valbiotis ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Valbiotis's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Valbiotis (XPAR:ALVAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (XPAR:ALVAL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

8JD:Germany

Address

12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180

Website

http://www.valbiotis.com

Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.

Valbiotis (XPAR:ALVAL) Headlines

No Headlines